Real-world pharmacovigilance of risperidone: Analysis based on FAERS reports from physicians and pharmacists
From the perspectives of physicians and pharmacists, this research provides a unique and robust theoretical foundation for evaluating the safety profile of risperidone and offers direction for future studies on its adverse events.
Authors
- Xiaomin Lv (ORCID: https://orcid.org/0009-0005-0253-6479)
- Gang Hao (ORCID: https://orcid.org/0000-0003-1252-5771)
- Zhi Jia (ORCID: https://orcid.org/0000-0001-7977-6108)
- Na Li (ORCID: https://orcid.org/0000-0002-5504-4874)
- J. Zhou
- Yue Zan
Institutions
- Nantong University (CN)
- Suzhou Vocational University (CN)
- The Affiliated Taizhou People's Hospital of Nanjing Medical University (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-10-17
- DOI
- https://doi.org/10.1371/journal.pone.0331983
- Citations
- 1
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 1.31